Skip to main content
. 2024 Jul 31;19(7):e0290939. doi: 10.1371/journal.pone.0290939

Table 1. Patient characteristics.

Data are n (%) unless stated otherwise.

Total number of patients 878
Sex
Male 470 (53.5%)
Female 408 (46.5%)
Age (at time of informed consent)
Median (years) 67.8 (range: 35–91)
54 or younger 114 (13.0%)
55–64 years 241 (27.4%)
65–74 years 329 (37.5%)
75 or older 194 (22.1%)
Smoking history
Current 261 (29.7%)
Former 298 (33.9%)
Never 61 (6.9%)
Unknown 258 (29.4%)
Stage of disease at time of inclusion
Sage I-III 474 (54.0%)
Stage IV 404 (46.0%)
Histology
Adenocarcinoma 583 (66.4%)
Squamous cell carcinoma 193 (22.0%)
Adenosquamous carcinoma 10 (1.1%)
LCNEC 14 (1.6%)
Sarcomatoid carcinoma 8 (0.9%)
NOS or unknown 70 (8.0%)

LCNEC = large cell neuro-endocrine carcinoma. NOS = not otherwise specified.